Picard Medical, Inc. (PMI)

ASE – Цена в реальном времени. Валюта: USD

0.18

-0.02 (-12.14%)

При закрытии: May 12, 2026, 4:00 PM EDT

0.18

-0.00 (-1.01%)

После закрытия: May 12, 2026, 7:56 PM EDT

05.05.2026

Picard Medical Announces Pricing of $5 Million Offering

TUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the pricing of its "reasonable best efforts" offering with certain new and existing institutional investors for the purchase and sale of (i) 16,666,667 shares of the Company's common stock, par value $0.0001 per share (or common stock equivalents in lieu thereof) (the “Common Stock”), (ii) series A common warrants to purchase up to 16,666,667 shares of Common Stock (the “Series A Common Warrants”), and (iii) series B common warrants to purchase up to 16,666,667 shares of Common Stock (the “Series B Common Warrants” together with the Series A Common Warrants, the “Common Warrants”) (the “Offering”).

30.04.2026

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Banner Health has performed more than 50 SynCardia Total Artificial Heart implants, establishing itself as a leading center in total artificial heart therapy Banner Health has performed more than 50 SynCardia Total Artificial Heart implants, establishing itself as a leading center in total artificial heart therapy

29.04.2026

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

– Discussions to highlight total artificial heart therapy, advanced heart failure market, and next-generation platform development – TUCSON, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, announced today it has been featured in a two-part interview series with Joe Mullings, Chairman and Chief Executive Officer of The Mullings Group Companies, a premier global executive search firm specialized in the MedTech, HealthTech, and Life Sciences industries.

20.04.2026

Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors

Health care was the most significant detractor, led by weakness within life sciences tools and services, while consumer discretionary and IT also weighed on relative performance. Regal Rexnord Corp. performed strongly in the first quarter, primarily on account of a quarterly report that featured particularly strong orders owing to budding demand for data center products. Westlake Corp. outperformed in the first quarter due to the effects on global chemical markets from the conflict in Iran, which has had an extreme impact on supply.

16.04.2026

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

TUCSON, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC, (“SynCardia”) maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced its participation in the International Society for Heart and Lung Transplantation (“ISHLT”) 2026 Annual Meeting, to be held at the Metro Toronto Convention Centre in Toronto, Canada.

13.04.2026

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

NEW YORK--(BUSINESS WIRE)---- $PMI #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm ha.

13.04.2026

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 13, 2026.

Видео

No Data

There is no data to display

Пресс-релизы

05.05.2026

Picard Medical Announces Pricing of $5 Million Offering

30.04.2026

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

29.04.2026

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

13.04.2026

Picard Medical, Inc. (PMI)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Picard Medical, Inc. (PMI)

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Видео

No Data

Пресс-релизы

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Видео

No Data

Пресс-релизы

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

Search stocks

Picard Medical, Inc. (PMI)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Picard Medical, Inc. (PMI)

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Видео

No Data

Пресс-релизы

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Видео

No Data

Пресс-релизы

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

PMI CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026